February 7, 2017 / 2:17 PM / 10 months ago

BUZZ-Aurinia Pharmaceuticals Inc: Shares dip after CEO transition

** U.S.-listed shares of Canadian drug developer down 5 pct at $3.16 premarket

** Company’s board accepts resignation of its CEO Charles Rowland, effective immediately

** Names founder Dr. Richard Glickman as its new CEO

** Up to Monday’s close, stock had risen 53 pct in the past 12 months

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below